All Stories

  1. The Effects of Gabapentin on Post-Operative Pain and Anxiety, Morphine Consumption and Patient Satisfaction in Paediatric Patients Following the Ravitch Procedure—A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial

    Article • Journal of Clinical Medicine, August 2022, MDPI AG

    Henryk Mazurek

  2. Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)

    Article • Healthcare, April 2022, MDPI AG

    Henryk Mazurek

  3. Risk Factors and Protective Factors against Ventilator-Associated Pneumonia—A Single-Center Mixed Prospective and Retrospective Cohort Study

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Henryk Mazurek

  4. Lung function from school age to adulthood in primary ciliary dyskinesia

    Article • European Respiratory Journal, March 2022, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  5. Plastic Bronchitis—A Serious Rare Complication Affecting Children Only after Fontan Procedure?

    Article • Journal of Clinical Medicine, December 2021, MDPI AG

    Henryk Mazurek

  6. Automatic Continuous Control of Cuff Pressure and Subglottic Secretion Suction Used Together to Prevent Pneumonia in Ventilated Patients—A Retrospective and Prospective Cohort Study

    Article • Journal of Clinical Medicine, October 2021, MDPI AG

    Henryk Mazurek

  7. Relationship Between Air Pollution and the Concentration of Nitric Oxide in the Exhaled Air (FeNO) in 8–9-Year-Old School Children in Krakow

    Article • International Journal of Environmental Research and Public Health, June 2021, MDPI AG

    Henryk Mazurek

  8. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6

    Article • Clinical & Experimental Immunology, June 2021, Oxford University Press (OUP)

    Henryk Mazurek

  9. Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis – a randomized trial

    Article • Journal of Cystic Fibrosis, January 2021, Elsevier

    Henryk Mazurek

  10. Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis

    Article • Journal of Cystic Fibrosis, January 2021, Elsevier

    Henryk Mazurek

  11. Reduced Exercise Tolerance Does Not Always Mean Bronchial Asthma

    Article • Pediatric Allergy Immunology and Pulmonology, December 2020, Mary Ann Liebert Inc

    Henryk Mazurek

  12. Estimation of Proinflammatory Factors in the Saliva of Adult Patients with Cystic Fibrosis and Dental Caries

    Article • Medicina, November 2020, MDPI AG

    Henryk Mazurek

  13. Are patients with lung cystic fibrosis at increased risk for severe and fatal COVID-19? Interleukin-6 as a predictor of COVID-19 outcome

    Article • Polish Archives of Internal Medicine, October 2020, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Henryk Mazurek

  14. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis

    Article • Mediators of Inflammation, March 2020, Hindawi Publishing Corporation

    Henryk Mazurek

  15. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

    Article • Journal of Cystic Fibrosis, March 2020, Elsevier

    Henryk Mazurek

  16. Acute Subglottic Laryngitis. Etiology, Epidemiology, Pathogenesis and Clinical Picture

    Article • Advances in respiratory medicine, October 2019, MDPI AG

    Henryk Mazurek

  17. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study

    Article • September 2019, Springer Science + Business Media

    Henryk Mazurek

  18. Time trends in diagnostic testing for primary ciliary dyskinesia in Europe

    Article • European Respiratory Journal, July 2019, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek, Siobhan Carr

  19. Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma

    Article • Advances in Dermatology and Allergology, January 2019, Termedia Sp. z.o.o.

    Henryk Mazurek

  20. A 2-year-old girl with chronic crackles after respiratory syncytial virus infection: a case report

    Article • Journal of Medical Case Reports, September 2018, Springer Science + Business Media

    Henryk Mazurek

  21. Lung function in patients with Primary Ciliary Dyskinesia: an iPCD Cohort study

    Article • European Respiratory Journal, July 2018, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  22. Seasonality of sputum eosinophilia in adolescents with asthma remission: effects of montelukast

    Article • Pediatric Allergy and Immunology, July 2018, Wiley

    Henryk Mazurek

  23. Polish Society of Alergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma

    Article • Alergologia Polska - Polish Journal of Allergology, January 2018, Termedia Sp. z.o.o.

    Henryk Mazurek

  24. Growth and nutritional status, and their association with lung function: a study from the international Primary Ciliary Dyskinesia Cohort

    Article • European Respiratory Journal, December 2017, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  25. Zasady stosowania komór inhalacyjnych u dzieci

    Article • Pediatria Polska, May 2017, Termedia Sp. z.o.o.

    Henryk Mazurek

  26. Hypersensitivity Pneumonitis in an 11-Year-Old Boy—A Case Report

    Article • Pediatric Allergy Immunology and Pulmonology, March 2017, Mary Ann Liebert Inc

    Henryk Mazurek

  27. The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Claudia Kuehni, Henryk Mazurek

  28. Standardy opieki Europejskiego Towarzystwa Mukowiscydozy: zarządzanie jakością w zakresie mukowiscydozy

    Article • Pediatria Polska, September 2016, Termedia Sp. z.o.o.

    Henryk Mazurek

  29. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast

    Article • Pulmonary Pharmacology & Therapeutics, August 2016, Elsevier

    Henryk Mazurek

  30. Macrolide antibiotics in respiratory diseases. Recommendations of the Polish Expert Group — AD 2015

    Article • Pneumonologia i Alergologia Polska, January 2016, MDPI AG

    Henryk Mazurek

  31. ReCOMmendations for management of Preschool ASthma for General Practitioners – COMPAS GP

    Article • Family Medicine & Primary Care Review, January 2016, Termedia Sp. z.o.o.

    Henryk Mazurek

  32. Factors related to changes in the quality of life among Polish adolescents and adults with cystic fibrosis over a 1-year period

    Article • Patient Preference and Adherence, December 2015, Taylor & Francis

    Henryk Mazurek

  33. Problems of Patients with Cystic Fibrosis during Transition to Adulthood

    Article • Advances in respiratory medicine, September 2015, MDPI AG

    Henryk Mazurek

  34. Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS

    Article • Journal of Cystic Fibrosis, December 2014, Elsevier

    Henryk Mazurek

  35. Evaluation of step-down therapy from an inhaled steroid to montelukast in childhood asthma

    Article • Allergologia et Immunopathologia, July 2014, Codon Publications

    Henryk Mazurek

  36. Distribution of Antibodies to Selected Antigens of Pseudomonas aeruginosa in Children and Young Adults with Cystic Fibrosis

    Article • Advances in respiratory medicine, June 2014, MDPI AG

    Henryk Mazurek

  37. A Pharmacokinetics and Safety Comparison of a Highly Concentrated Tobramycin Solution with TOBI

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, June 2014, Mary Ann Liebert Inc

    Henryk Mazurek

  38. Quality of life in patients with cystic fibrosis depending on the severity of the disease and method of its treatment

    Article • Postępy Higieny i Medycyny Doświadczalnej, May 2014, De Gruyter

    Henryk Mazurek

  39. Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis

    Article • Pediatric Pulmonology, January 2014, Wiley

    Henryk Mazurek

  40. Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

    Article • Thorax, June 2013, BMJ

    Henryk Mazurek

  41. Patient’s perception of the meaning of life in cystic fibrosis – its evaluation with respect to the stage of the disease and treatment

    Article • Postępy Higieny i Medycyny Doświadczalnej, October 2012, De Gruyter

    Henryk Mazurek

  42. Liprotamase Long-term Safety and Support of Nutritional Status in Pancreatic-insufficient Cystic Fibrosis

    Article • Journal of Pediatric Gastroenterology and Nutrition, February 2012, Wolters Kluwer Health

    Henryk Mazurek

  43. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients

    Article • Journal of Cystic Fibrosis, December 2011, Elsevier

    Henryk Mazurek

  44. Is Prediction of the Allergic March Possible on the Basis of Nasal Cytology?

    Article • Advances in respiratory medicine, July 2010, MDPI AG

    Henryk Mazurek

  45. Regular vs prn nebulized treatment in wheeze preschool children

    Article • Allergy, September 2009, Wiley

    Henryk Mazurek

  46. A Formulation of Aerosolized Tobramycin (Bramitob??) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection

    Article • Pediatric Drugs, January 2007, Springer Science + Business Media

    Henryk Mazurek

  47. Input respiratory impedance measured by head generator in preschool children

    Article • Pediatric Pulmonology, January 2000, Wiley

    Henryk Mazurek

  48. Specificity and Sensitivity of Respiratory Impedance in Assessing Reversibility of Airway Obstruction in Children

    Article • CHEST Journal, April 1995, Elsevier

    Henryk Mazurek

  49. Persistent increased lung response to methacholine after normobaric hyperoxia in rabbits

    Article • Respiration Physiology, February 1995, Elsevier

    Henryk Mazurek

  50. Input respiratory impedance to estimate airway hyperreactivity in children: standard method versus head generator

    Article • European Respiratory Journal, March 1994, European Respiratory Society (ERS)

    Henryk Mazurek

  51. Low-frequency vs. High-frequency respiratory mechanics after methacholine challenge in artificially ventilated rabbits

    Article • Pediatric Pulmonology, November 1993, Wiley

    Henryk Mazurek